Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3387)
All Articles published online
|
Publishing Process of This Article
|
May 24, 2024 (publication date) through Mar 31, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ma XT, Ou K, Yang WW, Cao BY, Yang L. Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer. World J Clin Oncol 2024; 15(5): 635-643 [PMID: 38835847 DOI: 10.5306/wjco.v15.i5.635] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ma XT, Ou K, Yang WW, Cao BY, Yang L. Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer. World J Clin Oncol 2024; 15(5): 635-643 [PMID: 38835847 DOI: 10.5306/wjco.v15.i5.635] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v15/i5/635.htm |
| Number | Citing Articles |
| 1 |
Xiaoting Ma, Kai Ou, Wenwei Yang, Biyang Cao, Jie Chen, Qi Wang, Lizhen Gao, Lin Yang. First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort. Discover Oncology 2026; doi: 10.1007/s12672-026-04853-0
|